Pharma Competitive Intelligence: Warning Signs of Subpar Intelligence In the fiercely competitive pharmaceutical landscape, comprehensive and strategic competitive intelligence (CI) is crucial for success. Pharmaceutical companies rely on gaining insights…
The pharmaceutical industry is fiercely competitive, with companies constantly seeking to win in the marketplace. Pharma competitive intelligence is a decision-making tool, and it plays a crucial role in shaping…
Key Success Factor in Pharma Search and Evaluation and Due Diligence Licensing and partnering are critical growth strategies in the biopharma industry. The effectiveness of licensing and partnership relies heavily on…
Mastering the Valuation of Pharma and Biotech Assets and Businesses Properly valuing drug and biotechnology assets is essential for pharmaceutical enterprises, biotech companies, investors, and other healthcare stakeholders. Valuation provides…
Enhancing Biopharma Licensing and Partnering Through Comparative Evaluation The biopharmaceutical industry landscape is constantly evolving, and in-licensing and partnering deals are vital corporate strategies for driving innovation, devising new products,…
Strategies to Optimize Pharma Competitive Intelligence for Maximum ROI Competitive intelligence (CI) is a widely used decision-making tool in the biopharma industry. In order to seek competitive advantage, pharma and…
Effectively Integrating Competitor Analysis into New Product Planning to Maximize Biopharma Asset Value In the biopharmaceutical industry, the predominant focus of New Product Planning (NPP) initiatives often revolves around individual…
Understanding and Applying Discount Rates for Precise Biopharma Valuations Selecting the appropriate discount rate is essential for pharmaceutical and biotechnology valuations. The discount rate is one of the key drivers…
Finessing Pharma and Biotech Product Strategies in the Post-Inflation Reduction Act Era The recent passage of the Inflation Reduction Act (IRA) introduces sweeping changes for the biopharmaceutical industry through new…
Key Factors in Venture Capital Valuation of Healthcare and Life Sciences Startups Valuing early-stage healthcare and life sciences startups presents unique challenges due to their lack of revenue, high-risk profiles,…